Pulling SEC filings + quote and writing the call…

NATIONAL HEALTH INVESTORS INC
Next earnings Aug 4, 2026 · consensus $0.88 EPS, $111M rev
Quality triple-net senior-housing REIT with CPI-linked rent escalators, but trading near fair value with a stretched payout and rising leverage.
Revenue $80.1M · FY2025
Middling fundamentals offset by an attractive price (~48% below fair value) — worth a look on the value angle.
NHI is a self-managed healthcare REIT with 189 Real Estate Investment properties across 32 states (110 SHOs, 65 SNFs, 1 hospital) leased to 31 tenants on 10–15 year triple-net leases with CPI-linked escalators, plus a smaller SHOP segment of 26 properties (3,009 units) operated via third-party managers under RIDEA. The triple-net structure pushes opex risk to tenants and the CPI escalators provide modest organic growth, while the demographic tailwind from an aging population underpins long-term demand for both need-driven (ALF/SLC) and discretionary (ILF/EFC) communities. FY2025 results show the business is executing: revenue rose 47.1% to $80.1M (boosted by SHOP consolidation, since SHOP resident-fee revenue runs through the top line while triple-net rent does not), operating cash flow grew 13.9% to $237M, and equity is up 11.3% YoY.
The quality, however, is partly offset by capital intensity and a stretched payout. Capex jumped 86.2% to $294M — well above $237M of operating cash flow — meaning the company is funding growth and a $170M dividend (up 8.4%) with external capital; share count rose 5.9% and cash fell 19.2% to just $19.6M. Diluted EPS actually slipped 3.5% to $3.02 despite the revenue surge, so dividends paid ($170M) exceed GAAP net income attributable to common ($142M), a payout that only works because REIT distributions are measured against FFO, not EPS. Leverage at 0.83x liabilities/equity is reasonable for a REIT, but $1.26B of liabilities against $19.6M cash leaves no buffer if rates stay higher for longer or if a major tenant — the filing notes 31 tenants across the triple-net book — runs into operator stress.
Is NHI a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $35.8M | $48.8M | $54.4M | $80.1M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $112M | $66.4M | $136M | $138M | $142M |
| Diluted EPS | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 |
| Net margin | — | 185.5% | 277.9% | 253.6% | 177.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other event disclosure; routine update with no material financial impact
Annual meeting vote results disclosed (Item 5.07); routine governance outcome
Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally
Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally
Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally
Amendment to prior 8-K providing updated/supplemental information
2026 proxy filed: director slate, exec comp and auditor ratification
Sources: SEC EDGAR (CIK 0000877860, latest 10-Q filed 2026-05-04) · EODHD · Proprietary analysis · as of 6/25/2026, 1:21:55 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:21 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 0 sales
| 2026-06-15 | MCCABE ROBERT A JR Director | Buy | 890.00 @ $71.65 | $63.8K |
| 2026-06-05 | Jobe James R Director | Gift | 225.00 | |
| 2026-06-05 | Mendelsohn D. Eric CEO and President | Buy | 1.50K @ $68.84 | $103K |
| 2026-05-05 | Spaid John L CFO/EVP Finance | Tax | 314.00 @ $73.09 | $23.0K |
| 2026-05-05 | Mendelsohn D. Eric CEO and President | Tax | 394.00 @ $73.09 | $28.8K |
| 2026-05-05 | Travis David L SVP/Chief Accounting Officer | Tax | 282.00 @ $73.09 | $20.6K |
| 2026-03-03 | Donohue Lilly Director | Award | 1.27K | |
| 2026-03-03 | COLDEN TRACY M J Director | Award | 1.27K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 buy · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median